Pioneering cardiologist James Muller, MD, a winner of the Nobel Peace Prize, was one of the chief researchers that developed the concept of vulnerable plaques causing heart attacks. He was recently honored by the American College of Cardiology for his contributions.

Two experienced TAVR specialists—Sachin Goel, MD, and Michael Reardon, MD—examined the growing trend of younger, low-risk patients being recommended for TAVR over SAVR.

"If we do not attack the inflammation, we just are not going to get the best outcomes for our patients," one researcher told Cardiovascular Business. 

Janet Wei, MD, associate medical director of the Biomedical Imaging Research Institute, and co-director of the stress echocardiography lab at Cedars-Sinai Hospital, explains the current information on the INOCA and MINOCA.

TEER can significantly improve a patient's chances of survival, new findings confirm.

More than 100 U.S. medical societies—including the ACC, ASNC and others—have united in support of a new bill that would make a long-term impact on Medicare payments.

HFpEF now accounts for a majority of heart failure cases, highlighting the importance of ensuring both primary care providers and dedicated heart teams know as much about this topic as possible. 

According to the large new study, published in JACC: CardioOncology, atherosclerotic CVD is associated with an especially high risk of cancer.